Graphite Bio Announces Participation in Jefferies Healthcare Conference
June 01 2022 - 8:00AM
Business Wire
Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage,
next-generation gene editing company harnessing the power of
high-efficiency precision gene repair to develop therapies with the
potential to treat or cure serious diseases, today announced that
members of the management team will present at the Jefferies
Healthcare Conference on Wednesday, June 8, 2022, at 4 p.m. ET.
The presentation will be webcast live from Graphite Bio’s
website at www.graphitebio.com in the Investors section. A replay
of the webcast will be archived and available following the
event.
About Graphite Bio
Graphite Bio is a clinical-stage, next-generation gene editing
company harnessing the power of high-efficiency precision gene
repair to develop a new class of therapies to potentially cure a
wide range of serious and life-threatening diseases. Graphite Bio
is pioneering a precision gene editing approach that could enable a
variety of applications to transform human health through its
potential to achieve one of medicine’s most elusive goals: to
precisely “find & replace” any gene in the genome. Graphite
Bio’s UltraHDR™ gene editing platform is designed to precisely
correct genetic mutations, replace entire disease-causing genes
with functional genes or insert new genes into predetermined, safe
locations. The company was co-founded by academic pioneers in the
fields of gene editing and gene therapy, including Maria Grazia
Roncarolo, M.D., and Matthew Porteus, M.D., Ph.D.
Learn more about Graphite Bio by visiting www.graphitebio.com
and following the company on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220601005287/en/
Company: Stephanie Yao VP, Communications and Investor
Relations 443-739-1423 syao@graphitebio.com
Investors: Stephanie Ascher Stern IR, Inc. 212-362-1200
ir@graphitebio.com
Media: Sheryl Seapy Real Chemistry 949-903-4750
media@graphitebio.com
Graphite Bio (NASDAQ:GRPH)
Historical Stock Chart
From May 2024 to Jun 2024
Graphite Bio (NASDAQ:GRPH)
Historical Stock Chart
From Jun 2023 to Jun 2024